The Future of Healthcare is Wherever You Are

Vaxess imagines a needle-free, refrigeration-free future of administering therapeutics — from the comfort of your home, or anywhere you go.

Our Mission:

Mapping a future where anyone can benefit from next-gen therapies in a convenient, patient-friendly way.

Seeking to dismantle barriers to therapeutics use and vaccination, we work to overcome the limitations of conventional needle administration and create products that are just as effective, but also offer a vastly improved patient experience. That's why we designed the microarray patch (MAP) platform to be needle-free, virtually pain-free, easy-to-use, and flexible with a wide range of payloads.

Sound audacious? It is. We’ve got the research to back it up. Join us as we improve human health worldwide by radically improving the patient experience, and expanding access to next-gen therapeutics and vaccines.

We are a group of life scientists, engineers, and entrepreneurs challenging ourselves and others to create breakthrough biomedical innovation, and make it available to people everywhere.

Our Leadership

Rachel Sha

Chief Executive Officer, Board Member

Lynda Tussey, PhD

Chief Development Officer

Ray Knox

VP of Manufacturing

John Spiridigliozzi

VP of Product Development

Kathryn Kosuda, PhD

Co-Founder, Chief Scientific Officer, Board Member

Jonathan Kluge, PhD

VP of Research and Development

Weiner Tilsner

Head of Quality and Compliance

Livio Valenti

Co-founder, Senior VP of Operations and Public and Private Partnerships

Matthew Dirckx, PhD

VP of Engineering

Board of Directors

Peter Kolchinsky, PhD

Co-Founder and Managing Partner, RA Capital Management

Ann Dewitt, PhD

General Partner, The Engine

Fenel Eloi

Managing Partner, P&M Capital Partners

Advisory Board


David Kaplan, PhD

Professor of Engineering, Tufts University



Fiorenzo Omenetto, PhD

Scientific Co-Founder, Advisor



Dennis Giesing, PhD

Chief Scientific Officer, Taris Biomedical


Vaxess has raised grant and venture funding from esteemed groups in the biotechnology and healthcare space.


Investors



Grantors